Pharmacopsychiatry
DOI: 10.1055/a-2577-7214
Review

Patient and Physician Exposure to Artificial Intelligence Hype

Scott Monteith
1   Michigan State University College of Human Medicine, Traverse City Campus, Traverse City, Michigan, USA
,
Tasha Glenn
2   ChronoRecord Association, Fullerton, California, USA
,
John R. Geddes
3   Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK
,
Peter C. Whybrow
4   Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California Los Angeles (UCLA), Los Angel es, California, USA
,
Eric D. Achtyes
5   Department of Psychiatry, Western Michigan University Homer Stryker M.D. School of Medicine, Kalamazoo, Michigan, USA
,
Rita Bauer
6   Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus Medical Faculty, Technische Universität Dresden, Dresden, Germany
,
Michael Bauer
6   Department of Psychiatry and Psychotherapy, University Hospital Carl Gustav Carus Medical Faculty, Technische Universität Dresden, Dresden, Germany
› Institutsangaben

Abstract

Both patients and physicians are routinely exposed to the corporate promotion of artificial intelligence (AI) for healthcare products. Hype for AI products may impact both patient behavior and attitudes about healthcare. Corporate AI hype may intentionally overlook the known limitations associated with AI products and focus solely on potential benefits. As AI is increasingly integrated into medicine, physicians are also routinely subject to AI hype. As the promotion and use of AI products have grown dramatically in recent years, physicians should be aware of the potential benefits and risks of AI products despite the hype.



Publikationsverlauf

Eingereicht: 06. Januar 2025

Angenommen nach Revision: 10. März 2025

Artikel online veröffentlicht:
12. Mai 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany